Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

Cancer Research UK to test Asterias’ lung cancer vaccine

Cancer Research UK to test Asterias’ lung cancer vaccine

Cancer Research UK to test Asterias’ lung cancer vaccine. The vaccine could treat NSCLC patients who are at risk of relapse. ... Cancer Research UK is starting a clinical trial of a first-of-its-kind vaccine for non-small cell lung cancer (NSCLC) based

Latest news

  • AstraZeneca expands alliance with Bicycle Therapeutics AstraZeneca expands alliance with Bicycle Therapeutics

    The initial deal was signed 18 months ago and focused on using the UK biotech’s bicyclic peptide platform to develop drugs against multiple disease targets, none of which are being ... The biotech’s lead candidate is BT1718 for solid tumours, which

  • Daily brief:  Trump fails to ruffle PBMS, pharma, Jowell leaves brain tumour research legacy Daily brief:  Trump fails to ruffle PBMS, pharma, Jowell leaves brain tumour research legacy

    UK news. Brain cancer research funding boost in memory of Tessa Jowell. ... This has now been doubled to £40m, which will bring the total research fund to £65m, including £25m from Cancer Research UK and £13m of regular funding.

  • NICE says OK to Keytruda for bladder cancer via the CDF NICE says OK to Keytruda for bladder cancer via the CDF

    According to Cancer Research UK, urothelial cancer is the most common form of bladder cancer and accounts for over 90% of cases and it is the only top ten cancer where ... Louise Houson, UK managing director for MSD, said: “MSD is really pleased that

  • NICE backs EUSA's RCC treatment Fotivda NICE backs EUSA's RCC treatment Fotivda

    NICE backs EUSA's RCC treatment Fotivda. The UK’s cost-effectiveness watchdog recommends its first-line use. ... According to Cancer Research UK, around 12 people in the UK die every day of kidney cancer, with RCC being the most common form of kidney

  • Merck forges closer ties with Cancer Research UK Merck forges closer ties with Cancer Research UK

    Merck forges closer ties with Cancer Research UK. Will partake in three research projects covering hit discovery to preclinical candidate selection. ... Researchers at Merck KGaA will join forces with scientists at Cancer Research UK for an early-stage

More from news
Approximately 13 fully matching, plus 120 partially matching documents found.

Latest Intelligence

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of

  • Communicating health messages Communicating health messages

    Consider this impactful infographic from Cancer Research UK:. Now take a look at how such comparisons are normally presented in the media. ... them? They are human too. Source: Cancer Research UK. How data is framed can incite behaviour change .

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... to happen so we have the good political support underlined with

  • Communiqué Awards digital publication Communiqué Awards digital publication

    See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera strengthens its scientific advisory board and appoints CSO. Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Additionally, Dr Jon Roffey joins Glythera ’s scientific advisory board (SAB) from Cancer Research Technology (CRT), Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden to join BMS board. She will also serve on the pharma firm's Science and Technology Committee. ... Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    Sophie Adlard joins J D Consulting as a business analyst. She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British Pharmaceutical Industry (ABPI). ... He leaves his role as public affairs manager at Cancer Research UK.

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Why is the UK lagging behind the rest of Europe in cancer survival?

    Why is the UK lagging behind the rest of Europe in cancer survival? ... Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK.

  • World Cancer Day and the role of people-centred care

    Overview on Patient Centricity in Cancer Care. Front Pharmacol 2017; 8: 1-12. ... BMJ Innov 2017; 3(2): 76-83. World Cancer Day. Available at: . Accessed February 2018. Cancer Research UK. Available at: . Accessed February 2018.

  • Caring for prostate cancer patients

    Cancer Research UK estimates that  men in the UK have a 1 in 8 chance of developing prostate cancer at some point in their lives. ... From a personal perspective, I’ ve watched my grandfather receive his diagnosis of prostate cancer.

  • When is sun safety doing more harm than good?

    New figures from  Cancer Research UK warn that people over 65 are around seven times more likely to develop malignant melanoma - a type of skin cancer - compared to 40 years ago. ... Thankfully campaigns from charities such as Cancer Research UK that

  • Market Insights Can Deliver a Better Patient Experience

    Our team has been conducting a great deal of patient journey research lately. ... Cancer Research UK’ s Sunsmart campaign knew from their research that health safety messages were not going to change the behavior of young people who use sunbeds to tan

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics